First Three Facilities Accredited in SNMMI/IAC Radiopharmaceutical Therapy Accreditation Program

September 25, 2023

Reston, VA—The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the Intersocietal Accreditation Commission (IAC) are pleased to announce the first three facilities to be awarded the new Radiopharmaceutical Therapy Accreditation. The accreditation indicates proficiency and competency in radiopharmaceutical therapy, a powerful technique for treating cancer that is now being used to great benefit in patients with prostate and other cancers. 

The three accredited facilities are:

BAMF Health, of Grand Rapids, Michigan

Carilion Clinic Targeted Therapy Center, Roanoke, Virginia

Stanford Health Care, Stanford, California

The Radiopharmaceutical Therapy Accreditation Program was launched in June 2023. Centers who are awarded this prestigious accreditation have shown competency in radiopharmaceutical therapy, meet high standards of training and experience, have state-of-the-art equipment and facilities, and have shown consistency in providing high-quality, safe care to patients.

Facilities interested in receiving information about the new program are encouraged to visit to complete an interest form for the Radiopharmaceutical Therapy program.   


About the Society of Nuclear Medicine and Molecular Imaging

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and medical organization dedicated to advancing nuclear medicine and molecular imaging, vital elements of precision medicine that allow diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes.

SNMMI’s members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings and leading advocacy on key issues that affect molecular imaging and therapy research and practice. For more information, visit

About the Intersocietal Accreditation Commission

The IAC is a nonprofit organization in operation to evaluate and accredit facilities that provide diagnostic imaging, interventional and therapeutic procedures, thus improving the quality of patient care provided in private offices, clinics and hospitals where such services are performed. The IAC provides accreditation programs for vascular testing, echocardiography, nuclear/PET/radiopharmaceutical therapy, MRI, diagnostic CT, dental CT, carotid stenting, vascular interventional, cardiac electrophysiology and cardiovascular catheterization. The IAC programs for accreditation are dedicated to ensuring quality patient care and promoting health care and all support one common mission: Improving health care through accreditation®. Committed to its mission through a rigorous peer review process, the IAC has granted accreditation to more than 14,000 sites since its inception in 1991. To learn more about IAC, visit